HIT! High Impact Clinical Trials 4

30 Mar 2026 9:25 a.m. 10:55 a.m.

Main Hall

KeiFukami Chair Japan

LizLightstone Chair United Kingdom

MasaomiNangaku Chair Japan

Time	Session

9:25 a.m. 9:40 a.m.	EFFECT OF A 12-WEEK INTRADIALYTIC CYCLING INTERVENTION ON HEMODIALYSIS-INDUCED MYOCARDIAL STUNNING: A MULTI-CENTRE RANDOMIZED CONTROLLED TRIAL (TICKERS_HD) ClaraBohm Speaker Canada
9:40 a.m. 9:55 a.m.	EFFECT OF FINERENONE ON CIRCULATING BIOMARKERS: A CONFIDENCE ANALYSIS MarioBerger Speaker Germany
9:55 a.m. 10:10 a.m.	EFFECT OF SIMULTANEOUS INITIATION OF FINERENONE AND EMPAGLIFLOZIN ON URINARY ALBUMIN-TO-CREATININE RATIO BY AGE AND SEX IN THE CONFIDENCE TRIAL RajivAgarwal Speaker United States
10:10 a.m. 10:25 a.m.	A CONTROLLED, RANDOMIZED CLINICAL TRIAL OF PERSONALIZED TWO-PHASE REGIONAL CITRATE ANTICOAGULATION IN PROLONGED INTERMITTENT KIDNEY REPLACEMENT THERAPY QiZhang Speaker China
10:25 a.m. 10:40 a.m.	LOWERING-HYPERURICEMIA TREATMENT ON CARDIOVASCULAR OUTCOMES IN PERITONEAL DIALYSIS PATIENTS: A PROSPECTIVE, MULTICENTER, DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL Naya Huang Speaker China